+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Medical Grade Skincare Market by Product (Cleansers, Gels, Creams & Moisturizers, Masks & Serums), Active Ingredients (Alpha Hydroxy Acids, Ceramides, Ferulic Acid), Packaging Type, Indication, Distribution Channels, Revenue Distribution - Forecast 2024-2030

  • PDF Icon

    Report

  • 196 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5847147
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Medical Grade Skincare Market size was estimated at USD 96.82 billion in 2023, USD 104.30 billion in 2024, and is expected to grow at a CAGR of 8.19% to reach USD 168.06 billion by 2030.

Medical-grade skincare products are formulated with high-quality, potent ingredients and are usually available through licensed healthcare professionals such as dermatologists and physicians. Medical-grade skincare products are designed to address skin concerns and are often backed by scientific research and clinical testing. Medical-grade skincare products are generally formulated with higher concentrations of active ingredients such as retinoids, alpha hydroxy acids (AHAs), beta hydroxy acids (BHAs), antioxidants, and peptides. The growing demand for skin care products that offer advanced solutions and target specific skin concerns such as aging, acne, hyperpigmentation, and skin sensitivity is elevating the need for medical-grade skincare products. Limited availability and distribution channels that restrict consumer access, particularly those in remote areas with fewer healthcare professionals, hamper the market growth. The rising incorporation of cutting-edge technologies such as encapsulation systems, nanotechnology, and advanced delivery systems in medical-grade skincare products is expected to create opportunities for market growth.

Regional Insights

The presence of advanced healthcare infrastructure, rising consumer awareness, and strong demand for innovative skincare solutions are the factors responsible for the growth of the medical grade skin care market in the Americas. Consumers in the Americas increasingly prefer anti-aging skincare, and sun protection, which address specific skin concerns such as acne, hyperpigmentation, and rosacea, thereby creating a platform for the medical grade skin care market in the Americas. With the increasing influence of K-beauty and J-beauty trends, there is a growing interest in advanced skincare solutions and medical grade skincare products in Asia-Pacific to address specific skin concerns. Europe, with countries such as Germany, France, the United Kingdom, Italy, and Spain, represents a developing landscape for the medical grade skincare market owing to the well-established distribution networks, advanced healthcare systems, and a strong emphasis on skincare. Platforms, including eCommerce, are gaining significant traction in the Americas, Europe, and Asia-Pacific region, allowing medical-grade skincare brands to reach a broader customer base.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Medical Grade Skincare Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Medical Grade Skincare Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Medical Grade Skincare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ALASTIN Skincare, Inc. by Galderma Laboratories, L.P., Alkem Laboratories Ltd., AllerganAesthetics, Alpyn Beauty, AlumierMD Labs, Inc., AMP Medical, LLC, Aspect Skincare by Advanced Skin Technology Pty Ltd., Audaja Inc., Augustinus Bader, Beiersdorf AG, Bioderma, Cipla Limited, Colgate-Palmolive Company, CosMedical Technologies, Cosmetic Solutions, DefenAge by Progenitor Biologics, LLC, DERMAdoctor, LLC by NovaBay Pharmaceuticals, Eau Thermale Avene by Pierre Fabre Group, Environ Skin Care (Pty) Ltd., Epicutis, Episciences, Inc., ESK Care Pty Limited, Estée Lauder Companies Inc., Evolve Med Spa, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Honasa Consumer Ltd., Image Skincare, INSKIN Cosmedics Group Pty Ltd., Inspira Skin, iS Clinical, Jan Marini Skin Research, L'Oréal S.A., NEOCUTIS by Merz North America, Inc., NeoStrata Company, Inc. by Johnson & Johnson Services, Inc., Obagi Cosmeceuticals LLC, Piramal Pharma Limited, Revision Skincare, Sebapharma GmbH & CO. KG, Sente, Inc., Shiseido Company, Limited, Skin + Me, The Skincare Company, Topix Pharmaceuticals, Inc., Trilogy Laboratories, LLC, Unilever PLC, USRx LLC, and ZO Skin Health, Inc.

Market Segmentation & Coverage

This research report categorizes the Medical Grade Skincare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Cleansers
    • Gels, Creams & Moisturizers
    • Masks & Serums
  • Active Ingredients
    • Alpha Hydroxy Acids
    • Ceramides
    • Ferulic Acid
    • Hyaluronic Acid
    • Kojic Acid
    • Salicylic Acid
    • Vitamins
      • Vitamin A
      • Vitamin B
      • Vitamin C
      • Vitamin E
      • Vitamin K
  • Packaging Type
    • Bottle
    • Dispensing Pumps
    • Tube
  • Indication
    • Acne
    • Age Spots
    • Dry Skin
    • Fine Lines & Winkles
    • Hyperpigmentation
    • Skin Laxity
    • Sun Damage
  • Distribution Channels
    • Offline
      • Dermatology Clinics
      • Physicians
    • Online
  • Revenue Distribution
    • Sell-in
    • Sell-out
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New Jersey
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Medical Grade Skincare Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Medical Grade Skincare Market?
  3. What are the technology trends and regulatory frameworks in the Medical Grade Skincare Market?
  4. What is the market share of the leading vendors in the Medical Grade Skincare Market?
  5. Which modes and strategic moves are suitable for entering the Medical Grade Skincare Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Medical Grade Skincare Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing consumer inclination and awareness regarding the importance of skin health
5.1.1.2. Growing popularity of nonsurgical aesthetic procedures and utilization of medical grade skincare products
5.1.2. Restraints
5.1.2.1. Limited consumer awareness associated with medical grade skincare products
5.1.3. Opportunities
5.1.3.1. Development of new medical grade skincare products and formulations
5.1.3.2. Expanding accessibility and availability of medical grade skincare products on online channels
5.1.4. Challenges
5.1.4.1. Possible risks of products due to negative reactions to skin
5.2. Market Segmentation Analysis
5.2.1. Product: Rising demand for medical grade skincare products which can suit various skin types
5.2.2. Active Ingredients: Growing potential of hyaluronic acid due to its incredible capacity to retain moisture
5.2.3. Packaging Type: Increasing inclination towards dispensing tube-type medical grade skincare products due to its convenience and ease of use
5.2.4. Indication: Rising usage of medical grade skin care products to manage acne that helps to unclog pores and reduce inflammation
5.2.5. Distribution Channels: Growing availability of medical grade skincare products across online platforms as they offer convenience and broader selection
5.2.6. Revenue Distribution: Rising sell-out revenue with increasing consumption of medical grade skincare
5.3. Market Trend Analysis
5.3.1. Presence of major regional market vendors focusing on the introduction of clinically new formulations in Americas
5.3.2. Growing popularity of K-beauty and J-beauty expanding the scope of medical grade skincare products in Asia-Pacific region
5.3.3. Growing awareness about skincare coupled with an emphasis on personal grooming in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Medical Grade Skincare Market, by Product
6.1. Introduction
6.2. Cleansers
6.3. Gels, Creams & Moisturizers
6.4. Masks & Serums
7. Medical Grade Skincare Market, by Active Ingredients
7.1. Introduction
7.2. Alpha Hydroxy Acids
7.3. Ceramides
7.4. Ferulic Acid
7.5. Hyaluronic Acid
7.6. Kojic Acid
7.7. Salicylic Acid
7.8. Vitamins
7.9.1. Vitamin A
7.9.2. Vitamin B
7.9.3. Vitamin C
7.9.4. Vitamin E
7.9.5. Vitamin K
8. Medical Grade Skincare Market, by Packaging Type
8.1. Introduction
8.2. Bottle
8.3. Dispensing Pumps
8.4. Tube
9. Medical Grade Skincare Market, by Indication
9.1. Introduction
9.2. Acne
9.3. Age Spots
9.4. Dry Skin
9.5. Fine Lines & Winkles
9.6. Hyperpigmentation
9.7. Skin Laxity
9.8. Sun Damage
10. Medical Grade Skincare Market, by Distribution Channels
10.1. Introduction
10.2. Offline
10.3.1. Dermatology Clinics
10.3.2. Physicians
10.3. Online
11. Medical Grade Skincare Market, by Revenue Distribution
11.1. Introduction
11.2. Sell-in
11.3. Sell-out
12. Americas Medical Grade Skincare Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Medical Grade Skincare Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Medical Grade Skincare Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
15.3.1. Merger & Acquisition
15.3.1.1. Shiseido to Acquire Dr. Dennis Gross Skincare
15.3.2. New Product Launch & Enhancement
15.3.2.1. Revision Skincare Unveils ‘Science Is Black and White’ Brand Campaign Alongside New Innovation
15.3.2.2. Alumier Introduces its Latest Refining Clay Mask
15.3.2.3. Skin Rx Launches Preventive, Medical-Grade Skincare for Gen Z
15.3.2.4. AlumierMD Unveils New Wellness Assets
15.3.2.5. Evolve Med Spa Launches Medical-Grade Skincare Line
15.3.3. Investment & Funding
15.3.3.1. INSKIN COSMEDICS Secures Funding to Accelerate Growth
15.3.3.2. Skin Pharm Raises USD 15 Million To Expand Clinics, Scale Aesthetic Dermatology Practice
15.3.3.3. Hand & Stone Further Invests into Skin Care and Facial Enhancements
15.3.3.4. GetHarley Raises USD 52 million to Connect Consumers With World-Class Clinicians and Medical-Grade Skincare Products
15.3.3.5. UK-based Skin + Me secures over EUR 11 million for its Personalized Prescription-Based Approach To Skincare
15.3.4. Award, Recognition, & Expansion
15.3.4.1. Galderma Announces Launch in the UK and Direct Distribution and Expansion in Canada
16. Competitive Portfolio
16.1. Key Company Profiles
16.1.1. Abbott Laboratories
16.1.2. ALASTIN Skincare, Inc. by Galderma Laboratories, L.P.
16.1.3. Alkem Laboratories Ltd.
16.1.4. AllerganAesthetics
16.1.5. Alpyn Beauty
16.1.6. AlumierMD Labs, Inc.
16.1.7. AMP Medical, LLC
16.1.8. Aspect Skincare by Advanced Skin Technology Pty Ltd.
16.1.9. Audaja Inc.
16.1.10. Augustinus Bader
16.1.11. Beiersdorf AG
16.1.12. Bioderma
16.1.13. Cipla Limited
16.1.14. Colgate-Palmolive Company
16.1.15. CosMedical Technologies
16.1.16. Cosmetic Solutions
16.1.17. DefenAge by Progenitor Biologics, LLC
16.1.18. DERMAdoctor, LLC by NovaBay Pharmaceuticals
16.1.19. Eau Thermale Avene by Pierre Fabre Group
16.1.20. Environ Skin Care (Pty) Ltd.
16.1.21. Epicutis
16.1.22. Episciences, Inc.
16.1.23. ESK Care Pty Limited
16.1.24. Estée Lauder Companies Inc.
16.1.25. Evolve Med Spa
16.1.26. GlaxoSmithKline PLC
16.1.27. Glenmark Pharmaceuticals Limited
16.1.28. Honasa Consumer Ltd.
16.1.29. Image Skincare
16.1.30. INSKIN Cosmedics Group Pty Ltd.
16.1.31. Inspira Skin
16.1.32. iS Clinical
16.1.33. Jan Marini Skin Research
16.1.34. L'Oréal S.A.
16.1.35. NEOCUTIS by Merz North America, Inc.
16.1.36. NeoStrata Company, Inc. by Johnson & Johnson Services, Inc.
16.1.37. Obagi Cosmeceuticals LLC
16.1.38. Piramal Pharma Limited
16.1.39. Revision Skincare
16.1.40. Sebapharma GmbH & CO. KG
16.1.41. Sente, Inc.
16.1.42. Shiseido Company, Limited
16.1.43. Skin + Me
16.1.44. The Skincare Company
16.1.45. Topix Pharmaceuticals, Inc.
16.1.46. Trilogy Laboratories, LLC
16.1.47. Unilever PLC
16.1.48. USRx LLC
16.1.49. ZO Skin Health, Inc.
16.2. Key Product Portfolio
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. MEDICAL GRADE SKINCARE MARKET RESEARCH PROCESS
FIGURE 2. MEDICAL GRADE SKINCARE MARKET SIZE, 2023 VS 2030
FIGURE 3. MEDICAL GRADE SKINCARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MEDICAL GRADE SKINCARE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MEDICAL GRADE SKINCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MEDICAL GRADE SKINCARE MARKET DYNAMICS
FIGURE 7. MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. MEDICAL GRADE SKINCARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2023 VS 2030 (%)
FIGURE 10. MEDICAL GRADE SKINCARE MARKET SIZE, BY ACTIVE INGREDIENTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2023 VS 2030 (%)
FIGURE 12. MEDICAL GRADE SKINCARE MARKET SIZE, BY PACKAGING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 14. MEDICAL GRADE SKINCARE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
FIGURE 16. MEDICAL GRADE SKINCARE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 18. MEDICAL GRADE SKINCARE MARKET SIZE, BY REVENUE DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES MEDICAL GRADE SKINCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA MEDICAL GRADE SKINCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. MEDICAL GRADE SKINCARE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 28. MEDICAL GRADE SKINCARE MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Abbott Laboratories
  • ALASTIN Skincare, Inc. by Galderma Laboratories, L.P.
  • Alkem Laboratories Ltd.
  • AllerganAesthetics
  • Alpyn Beauty
  • AlumierMD Labs, Inc.
  • AMP Medical, LLC
  • Aspect Skincare by Advanced Skin Technology Pty Ltd.
  • Audaja Inc.
  • Augustinus Bader
  • Beiersdorf AG
  • Bioderma
  • Cipla Limited
  • Colgate-Palmolive Company
  • CosMedical Technologies
  • Cosmetic Solutions
  • DefenAge by Progenitor Biologics, LLC
  • DERMAdoctor, LLC by NovaBay Pharmaceuticals
  • Eau Thermale Avene by Pierre Fabre Group
  • Environ Skin Care (Pty) Ltd.
  • Epicutis
  • Episciences, Inc.
  • ESK Care Pty Limited
  • Estée Lauder Companies Inc.
  • Evolve Med Spa
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Honasa Consumer Ltd.
  • Image Skincare
  • INSKIN Cosmedics Group Pty Ltd.
  • Inspira Skin
  • iS Clinical
  • Jan Marini Skin Research
  • L'Oréal S.A.
  • NEOCUTIS by Merz North America, Inc.
  • NeoStrata Company, Inc. by Johnson & Johnson Services, Inc.
  • Obagi Cosmeceuticals LLC
  • Piramal Pharma Limited
  • Revision Skincare
  • Sebapharma GmbH & CO. KG
  • Sente, Inc.
  • Shiseido Company, Limited
  • Skin + Me
  • The Skincare Company
  • Topix Pharmaceuticals, Inc.
  • Trilogy Laboratories, LLC
  • Unilever PLC
  • USRx LLC
  • ZO Skin Health, Inc.

Methodology

Loading
LOADING...

Table Information